Alzheimer's disease continues to be a significant challenge, affecting countless lives globally. However, with every challenge comes an opportunity. Today, we introduce the "Benfotiamine Alzheimer's Clinical Exploration (BACE) - ADC-061 Trial," a pioneering study that delves into the potential of Benfotiamine, a vitamin derivative, in treating Alzheimer's disease. By participating, you or your loved ones…

A Groundbreaking Study Awaits Your Participation! For those navigating the maze of Alzheimer's disease, it's not just memory loss that's a concern. Many patients with Alzheimer's also face the challenges of psychosis – symptoms like hallucinations or delusions that can be deeply distressing. And for their families and caregivers, watching a loved one grapple with these…